News und Analysen

After tanking in early August, the world’s most valuable pharmaceutical stock has roared back with a vengeance. That firm is Eli Lilly and Company (NYSE: LLY), the maker of the wildly popular

With many stocks looking overvalued, many investors may be tempted to sell. However, there are several factors to consider before taking profits:

• Time horizon – when an investor will need the

Marvell Technology (NASDAQ: MRVL) insiders are purchasing shares, and there are compelling reasons for investors to take notice. The company is well-positioned to benefit from the growth and

When investors hear that a company will lower prices on its products, their instinctive reaction is to expect a sequential decline in margins and profits, which is not entirely incorrect. However

On Sept. 30, the market delivered a powerful and unambiguous verdict on Draganfly Inc. (NASDAQ: DPRO). Shares of the drone technology company surged over 17%, driven by an unprecedented wave of

SoundHound’s (NASDAQ: SOUN) share price advanced by more than 10% on September 23rd to set a fresh long-term high and potentially break the market out of its trading range. The implication of

In the United States' healthcare sector, a new growth theme is emerging that nearly all companies want to capitalize on. Like artificial intelligence for technology stocks, weight loss drug